Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Extemporaneous compounding of dabrafenib and trametinib for cancer patients with feeding tubes.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners - 1 Sept 2023

Bui Trinh, Vu Van, Luon Darren

Abstract excerpt

INTRODUCTION: Dabrafenib and trametinib are oral targeted agents indicated for BRAF mutated non-small cell lung cancer and melanoma. There is little data to support the administration of these two agents via enteral feeding tube. This case series describes three patients who received compounded dabrafenib and trametinib suspensions through enteral feeding tubes. CASE REPORT: We present three patients who required...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Lung Neoplasms

Share to Melanoma

Share to Mutation

Share to Oximes

Share to Proto-Oncogene Proteins B-raf

Share to Pyrimidinones

Source

Identifiers

PMID: 37157852
DOI: 10.1177/10781552231175087

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Extemporaneous compounding of dabrafenib and trametinib for cancer patients with feeding tubes.PMID 37157852Read ↗

Successful use of crushed formulation of dabrafenib and trametinib in a pediatric glioneural tumor.Semantic proximity Read ↗

Beyond QTPP: Introducing the Quality Target Administration (QTAP) Profile for Enteral Feeding Tube MedicationsSemantic proximity Read ↗

Management of Pyrexia Associated with the Combination of Dabrafenib and Trametinib: Canadian Consensus Statements.Semantic proximity Read ↗

Relatively mild symptoms after chronic overdose with a double-dose encorafenib: a case report.Semantic proximity Read ↗

Nasogastric administration of osimertinib suspension for an epidermal growth factor receptor-mutated lung cancer causing an esophageal stricture: case report.Semantic proximity Read ↗

Advancements in Drug Delivery Systems from Chewable Tablets to NanomedicineSemantic proximity Read ↗

Frequency and component analysis of contaminants generated in preparation of anticancer agents using Closed system drug transfer devices (CSTDs)Semantic proximity Read ↗

Implementation of a Free Water Protocol at a Long Term Acute Care Hospital: A Feasibility StudySemantic proximity Read ↗

Radical esophagectomy for esophageal cancer with a bronchial occluder placed within a tracheotomy trocar: a case reportSemantic proximity Read ↗

Gastrointestinal perforation following dabrafenib and trametinib administration in non-small cell lung carcinoma with BRAF V600E mutation: a case report and literature reviewSemantic proximity Read ↗

Extraction of a metallic susceptor after accidental ingestion of the heated tobacco product TEREA™: a case reportSemantic proximity Read ↗

Treatment of chronic hepatitis C virus infection with crushed ledipasvir/sofosbuvir administered through a percutaneous endoscopic gastrostomy tube in a patient with HIV coinfection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.